High activity, high purity CD40L protein for co-stimulatory activation of an immune response
- Highly active MEGACD40L® oligomer mimics in vivo membrane-assisted CD40L aggregation and stimulation without the need for enhancers
- High purity with low endotoxin levels
- Experienced manufacturing results in consistent and dependable lot-to-lot performance
- Optimized formulation for improved stability and enhanced activity
MEGACD40L® is a high activity protein in which two trimeric CD40 ligand molecules are artificially linked via the collagen domain of Adiponectin/ACRP30/AdipoQ. This protein very effectively simulates the natural membrane-assisted aggregation of CD40L in vivo. It provides a simple and equally potent alternative to [CD40L+enhancer] combinations (Prod. No. ALX-850-064).
Shipping: Available products typically ship within 24/48h, via priority shipping.
Do you need support? Contact Customer Service or Technical Support.
Online Account
Access or Create Your Account

B cell lymphocyte activation by MEGACD40L® (Prod. No. ALX-522-110). Method: Peripheral Blood Mononuclear Cells (PBMCs) were incubated at 37°C, 5% CO2 for 48 hours in 48 well plates (1 x 106 cells/well). Each well contained 200µl serum free test media with serially diluted MEGACD40L®. After treatment, cells were washed and dual-stained with mouse anti-human CD19–PE and mouse anti-human CD86–APC and analyzed by flow cytometry. The data are presented as the percent of CD19 positive B cells that co-stain as CD86 positive, at each concentration of MEGACD40L®.

PBMCs (peripheral blood mononuclear cells) were incubated at 37°C, 5% CO2 for 48 hours in 48 well plates (1 x 106 cells per well) containing 200µl serum free test media with serially diluted MEGACD40L® (Prod. No. ALX-522-110), CD40L (Prod. No. ALX-522-015), or CD40L + 2µg/ml Enhancer (Prod. No. ALX-804-034). After treatment the cells were washed 3X with PBS + 1% BSA. The cells were dual stained for 2 hours at 4°C with mouse anti-human CD19 (PE conjugate) and mouse anti-human CD86 (APC conjugate). The cells were washed 2X with PBS + 1% BSA, then re-suspended In PBS. Samples were analyzed on a BD Facs Calibur flow cytometer. The data is presented as the percent of CD86 positive cells per CD19 positive B cells at each concentration.

MEGACD40L® from 7 consecutive manufacturing lots was tested using a B-cell activation assay at 1000ng/mL.





Product Details
Alternative Name |
CD40L:ACRP30headless, CD154:ACRP30headless, TNFSF 5:ACRP30headless, gp39:ACRP30headless |
---|---|
Application Notes |
Can be used to mediate immune and inflammatory responses, as a protein tool for pre-clinical studies in immunotherapy, to monitor patients undergoing chemotherapy and to mimic autoimmune phenotypes in vivo. |
Biological Activity |
Binds to human CD40. Induces B cells activation (as demonstrated by dose-dependent upregulation of CD86). |
Concentration |
0.1mg/ml after reconstitution. |
Endotoxin Content |
≤0.01EU/µg purified protein (LAL test; Cape Cod Associates). |
Formulation |
Lyophilized. Contains PBS. |
MW |
~38kDa |
Purity |
≥90% (SDS-PAGE) |
Purity Detail |
Purified by multi-step chromatography. |
Reconstitution |
Reconstitute with 100µl sterile water. Further dilutions should be made with medium containing 5% fetal calf serum. |
Source |
Produced in CHO cells. The extracellular domain of human CD40L (CD154) (aa 116-261) is fused at the N-terminus to mouse ACRP30headless (aa 18-111) and a FLAG®-tag. |
Technical Info / Product Notes |
FLAG is a registered trademark of Sigma-Aldrich Co. |
UniProt ID |
P29965 (human CD40L), Q60994 (mouse Adiponectin) |
Handling & Storage
Use/Stability |
Stable for at least 6 months after receipt when stored at -20°C. |
---|---|
Handling |
Avoid freeze/thaw cycles. After reconstitution, prepare aliquots and store at -20°C. |
Long Term Storage |
-20°C |
Shipping |
Blue Ice |
Regulatory Status |
RUO – Research Use Only |
---|
- Myricetin exposure reduces PC differentiation in vitro in primary human B cells: Haque, S., Diamond, B., et al.; Mol. Med. 31, 28 (2025), Abstract
- Multilayered HIV-1 resistance in HSPCs through CCR5 Knockout and B cell secretion of HIV-inhibiting antibodies: Feist, W. N., Luna, S. E., et al.; Nat. Commun. 16, 3103 (2025), Abstract
- Reduced response to SARS-CoV-2 vaccination is associated with impaired immunoglobulin class switch recombination in SLE patients: Montamat, G., Meehan, C. E., et al.; Clin. Exp. Immunol. 219, uxae119 (2025), Abstract
- The aryl hydrocarbon receptor differentially modulates the expression profile of antibody isotypes in a human B-cell line: Bhakta-Yadav, M. S., Burra, K., et al.; Toxicol. Sci. 199, 276 (2024), Abstract
- Inflammation induces α1-adrenoceptor expression in peripheral blood mononuclear cells of patients with complex regional pain syndrome: L.K. Wijaya, et al.; Brain Behav. Immun. 115, 201 (2024), Abstract
- Reduced response to SARS-CoV-2 vaccination is associated with impaired immunoglobulin class switch recombination in SLE patients: Montamat, G., Meehan, C. E., et al.; medRxiv , (2024)
- sciCSR infers B cell state transition and predicts class-switch recombination dynamics using single-cell transcriptomic data: Ng, J. C. F., Montamat, G., et al.; Nat. Methods 21, 823 (2024), Abstract
- High-efficiency transgene integration by homology-directed repair in human primary cells using DNA-PKcs inhibition: Selvaraj, S., Feist, W. N., et al.; Nat. Biotechnol. 42, 731 (2024), Abstract
- Biallelic human SHARPIN loss of function induces autoinflammation and immunodeficiency: Oda, H., Manthiram, K., et al.; Nat. Immunol. 25, 764 (2024), Abstract
- Distinct stage-specific transcriptional states of B cells derived from human tonsillar tissue: D.A. Espinoza, et al.; JCI Insight 8, e155199 (2023), Abstract
- Impact of the -1T>C single-nucleotide polymorphism of the CD40 gene on the development of endothelial dysfunction in a pro-diabetic microenvironment: P. Joshi, et al.; Atherosclerosis 14, 117386 (2023), Abstract
- Cell type-specific delivery by modular envelope design: Strebinger, D., Frangieh, C. J., et al.; Nat. Commun. 14, 5141 (2023), Abstract
- PD-1highCXCR5–CD4+ peripheral helper T cells promote CXCR3+ plasmablasts in human acute viral infection: H. Asashima, et al.; Cell Rep. 42, 111895 (2023), Abstract
- In vitro 2D and 3D cancer models to evaluate compounds that modulate macrophage polarization: N.H. Madsen, et al.; Cell. Immunol. 378, 104574 (2022), Abstract
- An optimized measles virus glycoprotein-pseudotyped lentiviral vector production system to promote efficient transduction of human primary B cells: E. Vamva, et al.; STAR Protoc. 3, 101228 (2022), Abstract
- Methionine metabolism controls the B cell EBV epigenome and viral latency: Guo, R., Liang, J. H., et al.; Cell Metab. 34, 1280 (2022), Abstract
- Human LUBAC deficiency leads to autoinflammation and immunodeficiency by dysregulation in TNF-mediated cell death: Oda, H., Manthiram, K., et al.; medRxiv , (2022)
- Single-cell Atlas of common variable immunodeficiency shows germinal center-associated epigenetic dysregulation in B-cell responses: Rodríguez-Ubreva, J., Arutyunyan, A., et al.; Nat. Commun. 13, 1779 (2022), Abstract
- Anti-CD40 Antibody Fused to CD40 Ligand Is a Superagonist Platform for Adjuvant Intrinsic DC-Targeting Vaccines: Ceglia, V., Zurawski, S., et al.; Front. Immunol. 12, 786144 (2022), Abstract
- The nuclear lamina binds the EBV genome during latency and regulates viral gene expression: Caruso, L. B., Guo, R., et al.; PLoS Pathog. 18, e1010400 (2022), Abstract
- Role of CD40 ligand-mediated endothelial cell-monocyte interaction at atherosclerosis predilection sites: S. Lont, et al.; Biochem. Pharmacol. 206, 115298 (2022), Abstract
- Single-Cell Atlas of Common Variable Immunodeficiency reveals germinal center-associated epigenetic dysregulation in B cell responses: Rodriguez-Ubreva, J., Arutyunyan, A., et al.; bioRxiv , (2021)
- Mutations in the transcription factor FOXO1 mimic positive selection signals to promote germinal center B cell expansion and lymphomagenesis: Roberto, M. P., Varano, G., et al.; Immunity 54, 1807 (2021), Abstract
- Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes: Robertson, C. C., Inshaw, J. R. J., et al.; Nat. Genet. 53, 962 (2021), Abstract
- Epstein-Barr Virus Induced Cytidine Metabolism Roles in Transformed B-Cell Growth and Survival: Liang, J. H., Wang, C., et al.; Mbio 12, e0153021 (2021), Abstract
- Distinct stage-specific transcriptional states of B cells in human tonsillar tissue: Espinoza, D. A., Le Coz, C., et al.; bioRxiv , (2021)
- T and B cell abnormalities, pneumocystis pneumonia, and chronic lymphocytic leukemia associated with an AIOLOS defect in patients: H.S. Kuehn, et al.; J. Exp. Med. 218, e20211118 (2021), Application(s):Flow Cytometry / Reactant(s): Human, Abstract
- Vaccine-induced ICOS+CD38+ circulating Tfh are sensitive biosensors of age-related changes in inflammatory pathways: Herati, R. S., Silva, L. V., et al.; Cell Rep. Med. 2, 100262 (2021), Abstract
- Inverse Regulation of Confluence-Dependent ADAMTS13 and von Willebrand Factor Expression in Human Endothelial Cells: M. Popa, et al.; Thromb. Haemost. , (2021), Abstract
- Quantitative assessment of NFκB transcription factor activity: T.J. Hunter, et al.; J. Immunol. Methods 2021, 112954 (2021), Abstract
- Renal Fibrosis Is Significantly Attenuated Following Targeted Disruption of Cd40 in Experimental Renal Ischemia: S. Zhang, et al.; J. Am. Heart Assoc. 9, e014072 (2020), Abstract — Full Text
- DNA methylation enzymes and PRC1 restrict B-cell Epstein-Barr virus oncoprotein expression: Guo, R., Zhang, Y., et al.; Nat. Microbiol. 5, 1051 (2020), Application(s): In Vitro, Abstract
- A Nonsense N -Terminus NFKB2 Mutation Leading to Haploinsufficiency in a Patient with a Predominantly Antibody Deficiency: Kuehn, H. S., Bernasconi, A., et al.; J. Clin. Immunol. 40, 1093 (2020), Abstract
- C1s Inhibition by BIVV009 (Sutimlimab) Prevents Complement-Enhanced Activation of Autoimmune Human B Cells In Vitro: P.A. Nikitin, et al.; J. Immunol. 202, 1200 (2019), Abstract — Full Text
- CRISPR/Cas9 Screens Reveal Multiple Layers of B cell CD40 Regulation: C. Jiang, et al.; Cell Rep. 28, 1307 (2019), Abstract — Full Text
- Epstein-Barr-Virus-Induced One-Carbon Metabolism Drives B Cell Transformation: L.W. Wang, et al.; Cell Metab. 30, 539 (2019), Abstract — Full Text
- Type 1-programmed dendritic cells drive antigen-specific latency reversal and immune elimination of persistent HIV-1: J. Kristoff, et al.; EBioMedicine 43, 295 (2019), Abstract — Full Text
- Second Case of HOIP Deficiency Expands Clinical Features and Defines Inflammatory Transcriptome Regulated by LUBAC: Oda, H., Beck, D. B., et al.; Front. Immunol. 10, 479 (2019), Abstract
- High PD-L1/CD86 MFI ratio and IL-10 secretion characterize human regulatory dendritic cells generated for clinical testing in organ transplantation: A.F. Zahorchak, et al.; Cell. Immunol. 323, 9 (2018), Abstract
- Engineering protein-secreting plasma cells by homology-directed repair in primary human B cells: K.L. Hung, et al.; Mol. Ther. 26, 456 (2018), Abstract
- In vitro antineoplastic effects of auranofin in canine lymphoma cells: H. Zhang, et al.; BMC Cancer 18, 522 (2018), Abstract — Full Text
- Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus: J.M. Riggs, et al.; Lupus Sci. Med. 5, e000261 (2018), Abstract — Full Text
- CD40L mediated alternative NFκB-signaling induces resistance to BCR-inhibitors in patients with mantle cell lymphoma: H. Rauert-Wunderlich, et al.; Cell Death Dis. 9, 86 (2018), Abstract — Full Text
- CD40L and TNF both activate the classical NF-κB pathway, which is not required for the CD40L induced alternative pathway in endothelial cells: J. Seigner, et al.; Biochem. Biophys. Res. Commun. 495, 1389 (2018), Abstract
- Human secretory IgM emerges from plasma cells clonally related to gut memory B cells and targets highly diverse commensals: G. Magri, et al.; Immunity 47, 118 (2017), Application(s):Cell Culture / Reactant(s): Human, Abstract — Full Text
- Cutting Edge: Active TGF-β1 Released from GARP/TGF-β1 Complexes on the Surface of Stimulated Human B Lymphocytes Increases Class-Switch Recombination and Production of IgA: O. Dedobbeleer, et al.; J. Immunol. 199, 391 (2017), Abstract — Full Text
- Arginine methylation catalyzed by PRMT1 is required for B cell activation and differentiation: S. Infantino, et al.; Nat. Commun. 8, 891 (2017), Application(s): B-cell activation, Abstract — Full Text
- Regulation of cell surface CB2 receptor during Human B cell activation and differentiation: J.T. Castaneda, et al.; J. Neuroimmune Pharmacol. 12, 544 (2017), Abstract — Full Text
- CD40 signaling in Graves disease is mediated through canonical and noncanonical thyroidal nuclear factor κB activation: H.J. Lee, et al.; Endocrinology 158, 410 (2017), Abstract — Full Text
- Down‐regulation of CD73 on B cells of patients with viremic HIV correlates with B cell activation and disease progression: E.S. Kim, et al.; J. Leukoc. Biol. 101, 1263 (2017), Abstract
- B-cell activation with CD40L or CpG measures the function of B-cell subsets and identifies specific defects in immunodeficient patients: E. Marasco, et al.; Eur. J. Immunol. 47, 131 (2017), Application(s): Human PBMC culture, Abstract — Full Text
- Expression of HIV-1 matrix protein p17 and association with B-cell lymphoma in HIV-1 transgenic mice: V.A. Carroll, et al.; PNAS 113, 13168 (2016), Application(s): Human B cells culture, Abstract — Full Text
- T-helper signals restore B-cell receptor signaling in autoreactive anergic B cells by upregulating CD45 phosphatase activity: P. Szodoray, et al.; J. Allergy Clin. Immunol. 138, 839 (2016), Application(s): Cell culture, Abstract
- CD40 expression in fibrocytes Is induced by TSH: potential synergistic immune activation: T. Mester, et al.; PLoS One 11, e0162994 (2016), Abstract — Full Text
- Distinct TLR-mediated cytokine production and immunoglobulin secretion in human newborn naïve B cells: M.A. Pettengill, et al.; Innate Immun. 22, 433 (2016), Abstract — Full Text
- A human monoclonal antibody targeting the conserved staphylococcal antigen IsaA protects mice against Staphylococcus aureus bacteremia: S. van den Berg, et al.; Int. J. Med. Microbiol. 305, 55 (2015), Application(s): ELISA, PCR of human blood samples, Abstract
- CD40L Induces Functional Tunneling Nanotube Networks Exclusively in Dendritic Cells Programmed by Mediators of Type 1 Immunity: C. Zaccard, et al.; J. Immunol. 194, 1047 (2015), Application(s): Activation of mature human dendritic cells, Abstract
- Systemic agonistic anti-CD40 treatment of tumor-bearing mice modulates hepatic myeloid-suppressive cells and causes immune-mediated liver damage: J. Medina-Echeverz, et al.; Cancer Immunol. Res. 3, 557 (2015), Abstract — Full Text
- Detection of IκB degradation dynamics and IκB-α ubiquitination: P. Starokadomskyy, et al.; Methods Mol. Biol. 1280, 15 (2015), Abstract
- Mechanism and functional impact of CD40 ligand-induced von Willebrand factor release from endothelial cells: K. Möller, et al.; Thromb. Haemost. 113, 1095 (2015), Abstract
- Establishing the pig as a large animal model for vaccine development against human cancer: N.H. Overgaard, et al.; Front. Genet. 6, 286 (2015), Abstract — Full Text
- Haploinsufficiency of the NF-κB1 subunit p50 in common variable immunodeficiency: M. Fliegauf, et al.; Am. J. Hum. Genet. 97, 389 (2015), Abstract — Full Text
- NF-κB, p38 MAPK, ERK1/2, mTOR, STAT3 and increased glycolysis regulate stability of paricalcitol/dexamethasone-generated tolerogenic dendritic cells in the inflammatory environment: K. Danova, et al.; Oncotarget 6, 14123 (2015), Abstract — Full Text
- Phenotypic Approaches to Identify Inhibitors of B Cell Activation: E. B. Rex, et al.; J. Biomol. Screen. 20, 876 (2015), Application(s): Assay, Abstract — Full Text
- Thyrotropin receptor and CD40 mediate interleukin-8 expression in fibrocytes: implications for thyroid-associated ophthalmopathy (an American Ophthalmological Society thesis).: R. Douglas, et al.; Trans. Am. Ophthalmol. Soc. 12, 26 (2014), Application(s): In vitro analysis of human fibrocytes, Abstract — Full Text
- A GPBAR1 (TGR5) small molecule agonist shows specific inhibitory effects on myeloid cell activation in vitro and reduces experimental autoimmune encephalitis (EAE) in vivo: N. Lewis, et al.; PLoS One 9, e100883 (2014), Application(s): Assay of human PBMC, Abstract — Full Text
- Development of a novel anti-canine CD20 monoclonal antibody with diagnostic and therapeutic potential: D. Ito, et al.; Leuk. Lymphoma 56, 219 (2014), Application(s): Analysis of canine B-cell lymphoma cells, Abstract
- Exosomes Derived from Burkitt’s Lymphoma Cell Lines Induce Proliferation, Differentiation, and Class-Switch Recombination in B Cells: C. Gutzeit, et al.; J. Immunol. 192, 5852 (2014), Application(s): PCR, Assay of human B cells, Abstract — Full Text
- Preclinical evaluation of the novel, orally bioavailable Selective Inhibitor of Nuclear Export (SINE) KPT-335 in spontaneous canine cancer: results of a phase I study: C. London, et al.; PLoS One 9, e87585 (2014), Application(s): Analysis of canine tumor cells by WB, FLOW, Abstract — Full Text
- AMPKα1 deficiency amplifies proinflammatory myeloid APC activity and CD40 signaling: K.C. Carroll, et al.; J. Leukoc. Biol. 94, 1113 (2013), Abstract
- Blood CD4+CD45RO+CXCR5+ T cells are decreased but partially functional in signal transducer and activator of transcription 3 deficiency: F. Mazerolles, et al.; J. Allergy Clin. Immunol. 131, 1146 (2013), Application(s): Assay of blood cells, Abstract
- CD40 ligand is necessary and suffi cient to support primary diff use large B-cell lymphoma cells in culture: a tool for in vitro preclinical studies with primary B-cell malignancies: D. Ito, et al.; Leuk. Lymphoma 53, 1390 (2012), Application(s): Flow cytometry of human B cells, Abstract — Full Text
- Interleukin-6 Production in CD40-Engaged Fibrocytes in Thyroid-Associated Ophthalmopathy: Involvement of Akt and NF-κB: E.F. Gillespie, et al.; Invest. Ophthalmol. Vis. Sci. 53, 7746 (2012), Application(s): CD40 ligation, induction and signaling in Graves’ orbital fibroblasts (GOFB) and fibrocytes, Abstract — Full Text
- Siglec-7 tetramers characterize B-cell subpopulations and leukemic blasts: F. Gieseke, et al.; Eur. J. Immunol. 42, 2176 (2012), Application(s): ELISA of human B cells , Abstract — Full Text
- Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency: B. Boisson, et al.; Nat. Immunol. 13, 1178 (2012), Application(s): ELISA of human blood cells, Abstract — Full Text
- Stromal endothelial cells establish a bidirectional crosstalk with chronic lymphocytic leukemia cells through the TNF-related factors BAFF, APRIL and CD40L: M. Cols, et al.; J. Immunol. 188, 6071 (2012), Application(s): UVEC & MVEC entothelial cell culture, Abstract — Full Text
- HIV-1 gp120 impairs the induction of B cell responses by TLR9-activated plasmacytoid dendritic cells: N.P. Chung, et al.; J. Immunol. 189, 5257 (2012), Application(s): Activation of dendritic cells, Abstract — Full Text
- Reconstitution of huPBL-NSG mice with donor-matched dendritic cells enables antigen-specific T-cell activation: A. Harui, et al.; J. Neuroimmune Pharmacol. 6, 148 (2011), Application(s): Activation of dendritic cells, Abstract — Full Text
- Study of patients with Hyper-IgM type IV phenotype who recovered spontaneously during late childhood and review of the literature: N. Karaca, et al.; Eur. J. Pediatr. 170, 1039 (2011), Application(s): Determining human B-cell function in Hyper-IgM blood samples, Abstract
- New mechanism of X-linked anhidrotic ectodermal dysplasia with immunodeficiency: impairment of ubiquitin binding despite normal folding of NEMO protein: M. Hubeau, et al.; Blood 118, 926 (2011), Abstract
- Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like Receptor 3 response and susceptibility to Herpes Simplex Encephalitis: R. Perez de Diego, et al.; Immunity 33, 400 (2010), Abstract
- Multimeric soluble CD40 ligand (sCD40L) efficiently enhances HIV specific cellular immune responses during DNA prime and boost with attenuated poxvirus ventors MVA and NYVAC expressing HIV antigens: C.E. Gomez, et al.; Vaccine 27, 3165 (2009), Abstract
- Impaired CD40L signaling is a cause of defective IL-12 and TNF-alpha production in Sezary syndrome: circumvention by hexameric soluble CD40L: L.E. French, et al.; Blood 105, 219 (2005), Abstract — Full Text
- Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex: N. Holler, et al.; Mol. Cell. Biol. 23, 1428 (2003), Abstract — Full Text
Related Products

Alternative Name | TNFRSF 5 |
---|---|
Application | WB |
Host | Rabbit |
Species Reactivity | Bovine, Dog, Guinea pig, Hamster, Human, Monkey, Mouse, Porcine, Rabbit, Rat, Sheep |

Alternative Name | CD154, TNFSF 5, gp39 |
---|---|
Purity | ≥95% (SDS-PAGE) |
Source | Produced in E. coli. The extracellular domain of human CD40L (CD154) (aa 116-261) is fused at the N-terminus to a linker peptide (6 aa) and a FLAG®-tag. |

Alternative Name | TNFRSF 5 |
---|---|
Purity | ≥95% (SDS-PAGE) |
Source | Produced in HEK 293 cells. The cysteine-rich region (aa 21-193) of human CD40 is fused to the Fc portion of human IgG1. |

Alternative Name | CD154, TNFSF 5, gp39 |
---|---|
Purity | ≥90% (SDS-PAGE) |
Source | Produced in HEK 293 cells. The extracellular domain of human CD40L (CD154) (aa 116-261) is fused at the N-terminus to the Fc portion of human IgG1 and a linker peptide (20 aa). |
Datasheet, Manuals, SDS & CofA
Manuals And Inserts
Certificate of Analysis
Please enter the lot number as featured on the product label
SDS
Enzo Life Science provides GHS Compliant SDS
If your language is not available please fill out the SDS request form